Background: Retroperitoneal or visceral sarcoma may recur with disease limi
ted to the abdomen and pelvis. In this clinical situation, further surgical
treatments in an attempt to control the disease may be appropriate. CT is
used to help select patients for additional surgical interventions.
Study Design: Preoperative abdominal and pelvic CT scans of 33 patients wit
h recurrent sarcoma were reviewed retrospectively. All patients underwent r
eoperative surgery and, when appropriate, perioperative intraperitoneal che
motherapy. Patients were divided into two groups according to survival and
disease status: alive with no evidence of disease (n = 7) and alive with di
sease or dead of disease (n = 26). Twenty-two CT indices were studied retro
spectively for each patient and evaluated statistically.
Results: The presence of large (greater than 5 cm) tumor volume in 3 of the
13 abdominopelvic regions resulted in a significant difference in the prog
nosis between the groups of patients. These findings included tumor,in the
left lower quadrant (p = 0.032), tumor in the pelvis (p = 0.008), and tumor
in the distal jejunum (p = 0.032). Two other CT indices that showed a sign
ificant difference in survival between the groups were involvement of five
abdominopelvic regions or fewer (p = 0.008) and a peritoneal cancer index o
f 15 or less (p = 0.03). A statistical approach using a tree-structured dia
gram showed that patients with tumor diameter greater than 5 cm in the pelv
is accompanied by tumor involvement of more than one segment of small bowel
had a 0% probability of postoperative disease-free survival. In contrast,
patients with tumor diameter less than 5 cm in the pelvis on CT had an 86%
probability of disease-free survival.
Conclusions: For patients with recurrent sarcoma, selection criteria were g
enerated by a preoperative CT of the abdomen and pelvis. In this disease, C
T was a reliable diagnostic test for predicting benefit from further surgic
al interventions and should be used in the future to help select patients f
or an aggressive versus a palliative approach. (J Am Coll Surg 2000;190:700
-710. (C) 2000 by the American College of Surgeons).